Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study

Abstract

Lipoprotein(a) [Lp(a)] is a complex polymorphic lipoprotein comprised of a low-density lipoprotein particle with one molecule of apolipoprotein B100 and an additional apolipoprotein(a) connected through a disulfide bond. The serum concentration is mostly genetically determined and only modestly influenced by diet and other lifestyle modifications. In recent years it has garnered increasing attention due to its causal role in pre-mature atherosclerotic cardiovascular disease and calcific aortic valve stenosis, while novel effective therapeutic options are emerging [apolipoprotein(a) antisense oligonucleotides and ribonucleic acid interference therapy]. Bibliometric descriptive analysis and mapping of the research literature were made using Scopus built-in services. We focused on the distribution of documents, literature production dynamics, most prolific source titles, institutions, and countries. Additionally, we identified historical and influential papers using Reference Publication Year Spectrography (RPYS) and the CRExplorer software. An analysis of author keywords showed that Lp(a) was most intensively studied regarding inflammation, atherosclerosis, cardiovascular risk assessment, treatment options, and hormonal changes in post-menopausal women. The results provide a comprehensive view of the current Lp(a)-related literature with a specific interest in its role in calcific aortic valve stenosis and potential emerging pharmacological interventions. It will help the reader understand broader aspects of Lp(a) research and its translation into clinical practice.

Mapping the landscape of research on insulin resistance: a visualization analysis of randomized clinical trials

“…Additionally, we utilized synthetic knowledge synthesis to generate concepts and themes, allowing us to identify hotspots in this field. Notably, Kokol and his colleagues have previously employed these pioneering methods [31,[73][74][75][76].…”

Lipoprotein(a)'s Role in Atherosclerosis and Aortic Stenosis: A Contemporary Literature Review

“…Studies have examined how statins, fibrates, and many other traditional cholesterol-reducing drugs influence the circulating levels of Lp(a) [ 20 ]. The study also highlighted that increased Lp(a) concentrations are independent endogenous risk factors for ASCVD attributable to genetic factors for which LPA gene encoding apo(a) is accountable.…”

Association of Lipoprotein and Apolipoprotein Ratios With Glycemic Levels in Individuals With Prediabetes: A Case-Control Study

“…Lipoprotein(a) (Lp(a)) is a variant of LDL and considered as an independent risk factor for CVD, as a study demonstrated that cardiovascular disorder risk increases proportionally with increasing Lp(a) levels [ 4 ]. Moreover, Lp(a) is highly associated with impaired glucose metabolism [ 5 ].…”